Ayoz, S. Et Al. 2021. Using RV/LV ratio and cardiac biomarkers to define the risk of mortality from pulmonary embolism. TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.69, no.3 , 297-306.

Ayoz, S., EROL, S., Kul, M., GÜRÜN KAYA, A., GÜRSOY ÇORUH, A., Savas, I., ... AYDIN, Ö.(2021). Using RV/LV ratio and cardiac biomarkers to define the risk of mortality from pulmonary embolism. TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.69, no.3, 297-306.

Ayoz, Sumeyye Et Al. "Using RV/LV ratio and cardiac biomarkers to define the risk of mortality from pulmonary embolism," TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.69, no.3, 297-306, 2021

Ayoz, Sumeyye Et Al. "Using RV/LV ratio and cardiac biomarkers to define the risk of mortality from pulmonary embolism." TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.69, no.3, pp.297-306, 2021

Ayoz, S. Et Al. (2021) . "Using RV/LV ratio and cardiac biomarkers to define the risk of mortality from pulmonary embolism." TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.69, no.3, pp.297-306.

@article{article, author={Sumeyye Ayoz Et Al. }, title={Using RV/LV ratio and cardiac biomarkers to define the risk of mortality from pulmonary embolism}, journal={TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX}, year=2021, pages={297-306} }